Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

Pemetrexed induces macrocytosis. ΔMCV > 5 fL on pemetrexed therapy correlated with better DCR, PFS and OS. These results deserve further validation in prospective studies.